{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:19:31Z","timestamp":1791523171075,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1124\/jpet.122.001367","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T21:30:21Z","timestamp":1674250221000},"page":"17-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cannabinoid Tolerance in S426A\/S430A x \u03b2-Arrestin 2 Knockout Double-Mutant Mice"],"prefix":"10.1016","volume":"385","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1791-2933","authenticated-orcid":false,"given":"Mary K.","family":"Piscura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana E.","family":"Sepulveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malabika","family":"Maulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e","family":"Guindon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela N.","family":"Henderson-Redmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.122.001367_bib1","doi-asserted-by":"crossref","first-page":"9790","DOI":"10.1074\/jbc.M112.438804","article-title":"Distinct roles of \u03b2-arrestin 1 and \u03b2-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor 1 (CB1)","volume":"288","author":"Ahn","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.122.001367_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fpls.2016.00019","article-title":"Cannabis sativa: The Plant of the Thousand and One Molecules","volume":"7","author":"Andre","year":"2016","journal-title":"Front Plant Sci"},{"key":"10.1124\/jpet.122.001367_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1124\/mol.111.074013","article-title":"Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands","volume":"81","author":"Atwood","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.122.001367_bib4","doi-asserted-by":"crossref","first-page":"23990","DOI":"10.1038\/s41598-021-03242-7","article-title":"Pharmacokinetics and central accumulation of delta-9-tetrahydrocannabinol (THC) and its bioactive metabolites are influenced by route of administration and sex in rats","volume":"11","author":"Baglot","year":"2021","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.122.001367_bib5","doi-asserted-by":"crossref","first-page":"R349","DOI":"10.1152\/ajpregu.00933.2005","article-title":"Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators","volume":"291","author":"Bradshaw","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.122.001367_bib6","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1046\/j.1471-4159.1999.0732447.x","article-title":"Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain","volume":"73","author":"Breivogel","year":"1999","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.122.001367_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/FBP.0b013e328308f1e6","article-title":"Sensitivity to delta9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2 -\/- mice","volume":"19","author":"Breivogel","year":"2008","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.122.001367_bib8","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.npp.1301643","article-title":"Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis","volume":"33","author":"D\u2019Souza","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.122.001367_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuropharm.2007.06.005","article-title":"Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1\/2 MAP kinase signaling","volume":"54","author":"Daigle","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001367_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1471-4159.2008.05336.x","article-title":"Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism","volume":"106","author":"Daigle","year":"2008","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.122.001367_bib11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1124\/mol.115.103176","article-title":"Mechanisms of Biased \u03b2-Arrestin-Mediated Signaling Downstream from the Cannabinoid 1 Receptor","volume":"89","author":"Delgado-Peraza","year":"2016","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.122.001367_bib12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1471-4159.2001.00333.x","article-title":"Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus","volume":"77","author":"Derkinderen","year":"2001","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.122.001367_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fphar.2016.00415","article-title":"Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex","volume":"7","author":"Diez-Alarcia","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.122.001367_bib14","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1074\/jbc.M708118200","article-title":"beta-arrestin-biased agonism at the beta2-adrenergic receptor","volume":"283","author":"Drake","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.122.001367_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-8993(95)01113-7","article-title":"Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice","volume":"706","author":"Fan","year":"1996","journal-title":"Brain Res"},{"key":"10.1124\/jpet.122.001367_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.phrs.2017.08.008","article-title":"Characterization of structurally novel G protein biased CB1 agonists: Implications for drug development","volume":"125","author":"Ford","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1124\/jpet.122.001367_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ntt.2015.12.004","article-title":"Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice","volume":"58","author":"Gilbert","year":"2016","journal-title":"Neurotoxicol Teratol"},{"key":"10.1124\/jpet.122.001367_bib18","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1210\/en.2011-1643","article-title":"Minireview: Endocannabinoids and gonadal hormones: bidirectional interactions in physiology and behavior","volume":"153","author":"Gorzalka","year":"2012","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.122.001367_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fphar.2019.00125","article-title":"GPCR Signaling Regulation: The Role of GRKs and Arrestins","volume":"10","author":"Gurevich","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.122.001367_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.mce.2013.03.013","article-title":"Differential \u03b2-arrestin2 requirements for constitutive and agonist-induced internalization of the CB1 cannabinoid receptor","volume":"372","author":"Gyombolai","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/jpet.122.001367_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.684115","article-title":"Sex Differences in Tolerance to Delta-9-Tetrahydrocannabinol in Mice With Cisplatin-Evoked Chronic Neuropathic Pain","volume":"8","author":"Henderson-Redmond","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1124\/jpet.122.001367_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107847","article-title":"c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific manner","volume":"164","author":"Henderson-Redmond","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001367_bib23","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00213-021-05886-9","article-title":"Sex-specific mechanisms of tolerance for the cannabinoid agonists CP55,940 and delta-9-tetrahydrocannabinol (\u03949-THC)","volume":"239","author":"Henderson-Redmond","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001367_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.122.001367_bib25","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.122.001367_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1471-4159.1999.0730493.x","article-title":"Internalization and recycling of the CB1 cannabinoid receptor","volume":"73","author":"Hsieh","year":"1999","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.122.001367_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/can.2016.0037","article-title":"Cannabinoid CB1 and CB2 Receptor Signaling and Bias","volume":"2","author":"Ibsen","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1124\/jpet.122.001367_bib28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fphar.2019.00350","article-title":"Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence","volume":"10","author":"Ibsen","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.122.001367_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0091-3057(01)00647-5","article-title":"Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids","volume":"71","author":"Janoyan","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.122.001367_bib30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/FJC.0000000000000482","article-title":"G Protein-Coupled Receptor Signaling Through \u03b2-Arrestin-Dependent Mechanisms","volume":"70","author":"Jean-Charles","year":"2017","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/jpet.122.001367_bib31","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1523\/JNEUROSCI.19-10-03773.1999","article-title":"Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization","volume":"19","author":"Jin","year":"1999","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.122.001367_bib32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/WNR.0000000000000993","article-title":"Sex differences in antinociceptive response to \u0394-9-tetrahydrocannabinol and CP 55,940 in the mouse formalin test","volume":"29","author":"LaFleur","year":"2018","journal-title":"Neuroreport"},{"key":"10.1124\/jpet.122.001367_bib33","doi-asserted-by":"crossref","first-page":"18677","DOI":"10.1074\/jbc.273.30.18677","article-title":"G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization","volume":"273","author":"Lefkowitz","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.122.001367_bib34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13293-021-00402-2","article-title":"Sex differences in the expression of the endocannabinoid system within V1M cortex and PAG of Sprague Dawley rats","volume":"12","author":"Levine","year":"2021","journal-title":"Biol Sex Differ"},{"key":"10.1124\/jpet.122.001367_bib35","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0022-3565(25)13256-4","article-title":"Pharmacology and stereoselectivity of structurally novel cannabinoids in mice","volume":"247","author":"Little","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001367_bib36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1037\/pha0000027","article-title":"The impact of gonadal hormones on cannabinoid dependence","volume":"23","author":"Marusich","year":"2015","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/jpet.122.001367_bib37","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1124\/jpet.107.130328","article-title":"Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol","volume":"324","author":"McKinney","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001367_bib38","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00213-021-05995-5","article-title":"Cannabinoid tetrad effects of oral \u03949-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations","volume":"239","author":"Moore","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001367_bib39","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1523\/JNEUROSCI.3445-12.2014","article-title":"Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice","volume":"34","author":"Morgan","year":"2014","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.122.001367_bib40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuropharm.2018.12.026","article-title":"Tolerance to WIN55,212-2 is delayed in desensitization-resistant S426A\/S430A mice","volume":"148","author":"Nealon","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001367_bib41","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.biopsych.2011.11.027","article-title":"\u03b2-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner","volume":"71","author":"Nguyen","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.122.001367_bib42","doi-asserted-by":"crossref","first-page":"PL1","DOI":"10.1016\/S0024-3205(98)00238-0","article-title":"Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors","volume":"63","author":"Petitet","year":"1998","journal-title":"Life Sci"},{"key":"10.1124\/jpet.122.001367_bib43","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1523\/JNEUROSCI.16-24-08057.1996","article-title":"Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain","volume":"16","author":"Sim","year":"1996","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.122.001367_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/jpet.102.035618","article-title":"Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice","volume":"303","author":"Sim-Selley","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001367_bib45","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1124\/mol.105.019612","article-title":"Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration","volume":"70","author":"Sim-Selley","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.122.001367_bib46","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1111\/j.1476-5381.2011.01743.x","article-title":"The CB1 cannabinoid receptor C-terminus regulates receptor desensitization in autaptic hippocampal neurones","volume":"165","author":"Straiker","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001367_bib47","doi-asserted-by":"crossref","first-page":"20577","DOI":"10.1074\/jbc.M513605200","article-title":"G-protein-coupled receptor kinase specificity for beta-arrestin recruitment to the beta2-adrenergic receptor revealed by fluorescence resonance energy transfer","volume":"281","author":"Violin","year":"2006","journal-title":"J Biol Chem"}],"updated-by":[{"DOI":"10.1124\/jpet.122.001367err","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000}}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524004245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524004245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.122.001367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:28:25Z","timestamp":1739971705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524004245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0022356524004245"],"URL":"https:\/\/doi.org\/10.1124\/jpet.122.001367","relation":{"erratum":[{"id-type":"doi","id":"10.1124\/jpet.122.001367err","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoid Tolerance in S426A\/S430A x \u03b2-Arrestin 2 Knockout Double-Mutant Mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.122.001367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}